Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells

Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea

(2012) Sydne J. Newberry   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

(2012) Oliver A Cornely et al.   LANCET INFECTIOUS DISEASES

Histamine Derived from Probiotic Lactobacillus reuteri Suppresses TNF via Modulation of PKA and ERK Signaling

(2012) Carissa M. Thomas et al.   PLoS One

Fecal transplant against relapsingClostridium difficile-associated diarrhea in 32 patients

(2012) Christina Jorup-Rönström et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection in 26 Patients

(2011) Colleen R. Kelly et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Risk Factors for Recurrence of Clostridium difficile Infection: Effect of Vancomycin-resistant Enterococci Colonization

(2011) Hee Kyoung Choi et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro

(2010) Fernando M. Trejo et al.   ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The Enterotoxicity of Clostridium difficile Toxins

(2010) Xingmin Sun et al.   Toxins

The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease

(2009) T. R. Hercus et al.   BLOOD

Lactobacillus saerimneriandLactobacillus ruminis: novel human-derived probiotic strains with immunomodulatory activities

(2009) Malai Taweechotipatr et al.   FEMS MICROBIOLOGY LETTERS

Treatment of Clostridium difficile-Associated Disease

(2009) Daniel A. Leffler et al.   GASTROENTEROLOGY

Clostridium difficile infection: new developments in epidemiology and pathogenesis

(2009) Maja Rupnik et al.   NATURE REVIEWS MICROBIOLOGY

Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells

(2009) Pratik Banerjee et al.   Gut Pathogens

Mechanisms of action of probiotics: Recent advances

(2008) S. C. Ng et al.   INFLAMMATORY BOWEL DISEASES

Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile

(2008) M. F. De La Cochetière et al.   MICROBIAL ECOLOGY

Clostridium difficile— More Difficult Than Ever

(2008) Ciarán P. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells

(2008) Akemi Imaoka et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events

(2007) Karen L. Mumy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY